Analysts Offer Predictions for SMMT Q2 Earnings
Summit Therapeutics Inc. (NASDAQ:SMMT – Free Report) – Equities research analysts at Leerink Partnrs issued their Q2 2025 earnings estimates for shares of Summit Therapeutics in a report issued on Wednesday, June 11th. Leerink Partnrs analyst D. Graybosch forecasts that the company will post earnings of ($0.09) per share for the quarter. Leerink Partnrs currently […]
Summit Therapeutics Inc. (NASDAQ:SMMT – Free Report) – Equities research analysts at Leerink Partnrs issued their Q2 2025 earnings estimates for shares of Summit Therapeutics in a report issued on Wednesday, June 11th. Leerink Partnrs analyst D. Graybosch forecasts that the company will post earnings of ($0.09) per share for the quarter. Leerink Partnrs currently […]
